Skip to main content

Animations

MJFF Publications

2541 - 2550 of 9038 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2023
  • 2023
  • 2022
  • Summary Details
    OPEN
    Title: Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
    Journal Name: Current Research in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.crneur.2022.100065
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Motor symptoms in Parkinson’s disease are related to the interplay between cortical curvature and thickness
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103300
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-022-05963-x
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29202
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29171
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29193
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.1061096
    Citation Count: 11
  • Summary Details
    OPEN
    Title: New protocol for kinetic assay seeding ability recovery “KASAR” from formalin-fixed paraffin-embedded tissues
    Journal Name: Frontiers in Molecular Biosciences
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fmolb.2023.1087982
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Sex-Specific Microglial Responses to Glucocerebrosidase Inhibition: Relevance to GBA1-Linked Parkinson’s Disease
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells12030343
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Transparent Exploration of Machine Learning for Biomarker Discovery from Proteomics and Omics Data
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.2c00473
    Citation Count: 68
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.